Our results suggested that Tim-3 and Galectin-9 blockade recovered IFN-γ and TNF-α production of T2DM NK cells but did not affect T2DM NK cell-mediated cytotoxicity. The gene discussed is LGALS9; the disease is type 2 diabetes mellitus.